247 related articles for article (PubMed ID: 34503197)
1. The Clinical Utility of Optical Genome Mapping for the Assessment of Genomic Aberrations in Acute Lymphoblastic Leukemia.
Lühmann JL; Stelter M; Wolter M; Kater J; Lentes J; Bergmann AK; Schieck M; Göhring G; Möricke A; Cario G; Žaliová M; Schrappe M; Schlegelberger B; Stanulla M; Steinemann D
Cancers (Basel); 2021 Aug; 13(17):. PubMed ID: 34503197
[TBL] [Abstract][Full Text] [Related]
2. Optical Genome Mapping for Comprehensive Assessment of Chromosomal Aberrations and Discovery of New Fusion Genes in Pediatric B-Acute Lymphoblastic Leukemia.
Gao H; Xu H; Wang C; Cui L; Huang X; Li W; Yue Z; Tian S; Zhao X; Xue T; Xing T; Li J; Wang Y; Zhang R; Li Z; Wang T
Cancers (Basel); 2022 Dec; 15(1):. PubMed ID: 36612032
[TBL] [Abstract][Full Text] [Related]
3. Next-generation cytogenetics: Comprehensive assessment of 52 hematological malignancy genomes by optical genome mapping.
Neveling K; Mantere T; Vermeulen S; Oorsprong M; van Beek R; Kater-Baats E; Pauper M; van der Zande G; Smeets D; Weghuis DO; Stevens-Kroef MJPL; Hoischen A
Am J Hum Genet; 2021 Aug; 108(8):1423-1435. PubMed ID: 34237281
[TBL] [Abstract][Full Text] [Related]
4. Optical genome mapping enables constitutional chromosomal aberration detection.
Mantere T; Neveling K; Pebrel-Richard C; Benoist M; van der Zande G; Kater-Baats E; Baatout I; van Beek R; Yammine T; Oorsprong M; Hsoumi F; Olde-Weghuis D; Majdali W; Vermeulen S; Pauper M; Lebbar A; Stevens-Kroef M; Sanlaville D; Dupont JM; Smeets D; Hoischen A; Schluth-Bolard C; El Khattabi L
Am J Hum Genet; 2021 Aug; 108(8):1409-1422. PubMed ID: 34237280
[TBL] [Abstract][Full Text] [Related]
5. Optical Genome Mapping Reveals and Characterizes Recurrent Aberrations and New Fusion Genes in Adult ALL.
Vieler LM; Nilius-Eliliwi V; Schroers R; Vangala DB; Nguyen HP; Gerding WM
Genes (Basel); 2023 Mar; 14(3):. PubMed ID: 36980958
[TBL] [Abstract][Full Text] [Related]
6. Optical Genome Mapping in Routine Cytogenetic Diagnosis of Acute Leukemia.
Soler G; Ouedraogo ZG; Goumy C; Lebecque B; Aspas Requena G; Ravinet A; Kanold J; Véronèse L; Tchirkov A
Cancers (Basel); 2023 Apr; 15(7):. PubMed ID: 37046792
[TBL] [Abstract][Full Text] [Related]
7. Optical Genome Mapping Reveals Novel Structural Variants in Lymphoblastic Lymphoma.
Xu H; Gao H; Wang C; Cheng X; Li Z; Lei C; Huang X; Li W; Yue Z; Tian S; Zhao X; Xue T; Xing T; Li J; Wang Y; Duan Y; Wang T; Zhang R
J Pediatr Hematol Oncol; 2024 Jan; 46(1):e71-e82. PubMed ID: 38018972
[TBL] [Abstract][Full Text] [Related]
8. Optical Genome Mapping as a Diagnostic Tool in Pediatric Acute Myeloid Leukemia.
Suttorp J; Lühmann JL; Behrens YL; Göhring G; Steinemann D; Reinhardt D; Neuhoff NV; Schneider M
Cancers (Basel); 2022 Apr; 14(9):. PubMed ID: 35565187
[TBL] [Abstract][Full Text] [Related]
9. Optimizing the diagnostic workflow for acute lymphoblastic leukemia by optical genome mapping.
Rack K; De Bie J; Ameye G; Gielen O; Demeyer S; Cools J; De Keersmaecker K; Vermeesch JR; Maertens J; Segers H; Michaux L; Dewaele B
Am J Hematol; 2022 May; 97(5):548-561. PubMed ID: 35119131
[TBL] [Abstract][Full Text] [Related]
10. Optical genome mapping in acute myeloid leukemia: a multicenter evaluation.
Levy B; Baughn LB; Akkari Y; Chartrand S; LaBarge B; Claxton D; Lennon PA; Cujar C; Kolhe R; Kroeger K; Pitel B; Sahajpal N; Sathanoori M; Vlad G; Zhang L; Fang M; Kanagal-Shamanna R; Broach JR
Blood Adv; 2023 Apr; 7(7):1297-1307. PubMed ID: 36417763
[TBL] [Abstract][Full Text] [Related]
11. Optical genome mapping, a promising alternative to gold standard cytogenetic approaches in a series of acute lymphoblastic leukemias.
Lestringant V; Duployez N; Penther D; Luquet I; Derrieux C; Lutun A; Preudhomme C; West M; Ouled-Haddou H; Devoldere C; Marolleau JP; Garçon L; Jedraszak G; Ferret Y
Genes Chromosomes Cancer; 2021 Oct; 60(10):657-667. PubMed ID: 33982372
[TBL] [Abstract][Full Text] [Related]
12. Comparison of Optical Genome Mapping With Conventional Diagnostic Methods for Structural Variant Detection in Hematologic Malignancies.
Shim Y; Koo YK; Shin S; Lee ST; Lee KA; Choi JR
Ann Lab Med; 2024 Jul; 44(4):324-334. PubMed ID: 38433573
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of optical genome mapping for detecting chromosomal translocation in clinical cytogenetics.
Dai P; Zhu X; Pei Y; Chen P; Li J; Gao Z; Liang Y; Kong X
Mol Genet Genomic Med; 2022 Jun; 10(6):e1936. PubMed ID: 35384386
[TBL] [Abstract][Full Text] [Related]
14. Implementation of RNA sequencing and array CGH in the diagnostic workflow of the AIEOP-BFM ALL 2017 trial on acute lymphoblastic leukemia.
Schieck M; Lentes J; Thomay K; Hofmann W; Behrens YL; Hagedorn M; Ebersold J; Davenport CF; Fazio G; Möricke A; Buchmann S; Alten J; Cario G; Schrappe M; Bergmann AK; Stanulla M; Steinemann D; Schlegelberger B; Cazzaniga G; Göhring G
Ann Hematol; 2020 Apr; 99(4):809-818. PubMed ID: 32078009
[TBL] [Abstract][Full Text] [Related]
15. Feasibility of Optical Genome Mapping in Cytogenetic Diagnostics of Hematological Neoplasms: A New Way to Look at DNA.
Coccaro N; Anelli L; Zagaria A; Tarantini F; Cumbo C; Tota G; Minervini CF; Minervini A; Conserva MR; Redavid I; Parciante E; Macchia MG; Specchia G; Musto P; Albano F
Diagnostics (Basel); 2023 May; 13(11):. PubMed ID: 37296693
[TBL] [Abstract][Full Text] [Related]
16. Cas9-directed long-read sequencing to resolve optical genome mapping findings in leukemia diagnostics.
de Boer EN; Vroom V; Scheper AJ; Johansson LF; Bosscher L; Rietema N; Commandeur-Jan SZ; Knoers NVAM; Sikkema-Raddatz B; van den Berg E; van Diemen CC
Sci Rep; 2024 Apr; 14(1):8508. PubMed ID: 38605095
[TBL] [Abstract][Full Text] [Related]
17. Optical Genome Mapping for Chromosomal Aberrations Detection-False-Negative Results and Contributing Factors.
Xu Y; Zhang Q; Wang Y; Zhou R; Ji X; Meng L; Luo C; Liu A; Jiao J; Chen H; Zeng H; Hu P; Xu Z
Diagnostics (Basel); 2024 Jan; 14(2):. PubMed ID: 38248042
[TBL] [Abstract][Full Text] [Related]
18. Cytogenetic Assessment and Risk Stratification in Myelofibrosis with Optical Genome Mapping.
Díaz-González Á; Mora E; Avetisyan G; Furió S; De la Puerta R; Gil JV; Liquori A; Villamón E; García-Hernández C; Santiago M; García-Ruiz C; Llop M; Ferrer-Lores B; Barragán E; García-Palomares S; Mayordomo E; Luna I; Vicente A; Cordón L; Senent L; Álvarez-Larrán A; Cervera J; De la Rubia J; Hernández-Boluda JC; Such E
Cancers (Basel); 2023 Jun; 15(11):. PubMed ID: 37297002
[TBL] [Abstract][Full Text] [Related]
19. Optical Genome Mapping in Routine Human Genetic Diagnostics-Its Advantages and Limitations.
Dremsek P; Schwarz T; Weil B; Malashka A; Laccone F; Neesen J
Genes (Basel); 2021 Dec; 12(12):. PubMed ID: 34946907
[TBL] [Abstract][Full Text] [Related]
20. Optical Genome Mapping as an Alternative to FISH-Based Cytogenetic Assessment in Chronic Lymphocytic Leukemia.
Valkama A; Vorimo S; Kumpula TA; Räsänen H; Savolainen ER; Pylkäs K; Mantere T
Cancers (Basel); 2023 Feb; 15(4):. PubMed ID: 36831635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
